glp-1 news updates november 2025 Retailers across the country are noticing a spike in returns of clothing as more Americans embrace drugs for weight loss. The rate of retail exchanges where shoppers traded clothing for a glp-1 shortage news november 2025

Mounjaro (tirzepatide): Manufactured by Eli Lilly and FDA-approved for type 2 diabetes, Mounjaro targets both GLP-1 and GIP receptors and has been widely prescribed off-label for weight loss

10.1249/MSS.0000000000002008 36

This blend allows researchers to study the co-activation of two distinct nutrient-response systems

The FDA has issued import alerts and warning letters to companies selling glutathione injections marketed for skin bleaching, particularly products imported from overseas markets where such claims are common

Later, it was approved for use in individuals with a body mass index (BMI) of 27 or above weight gain and those with at least one weight-related health problem, such as high blood pressure or type 2 diabetes, to promote weight loss